The information on this website is not intended for diagnosis or treatment. Please consult your physician for health concerns.

+90 850 321 50 00

Anticoagulant Therapy Management

Safe-use and monitoring guide for warfarin, DOACs, and heparin.

Written by: Saygı Hospital Health Guide Editorial Board
Published:

This content is for general information; please consult your physician for diagnosis and treatment.

This content is for informational purposes only and does not constitute medical advice. You can book an appointment at our Hematoloji department. Book Appointment →

What is Anticoagulant Therapy Management?

Anticoagulant therapy encompasses agents used in many clinical contexts, particularly for venous thromboembolism (DVT, pulmonary embolism) and stroke prophylaxis in atrial fibrillation. The main classes are heparins (UFH, LMWH), vitamin K antagonists (warfarin), and direct oral anticoagulants (DOACs: apixaban, rivaroxaban, edoxaban, dabigatran).

Warfarin requires regular INR monitoring due to its narrow therapeutic window and food/drug interactions. DOACs offer fixed dosing, fewer interactions, and no need for routine laboratory monitoring; however, in special situations (mechanical heart valve, antiphospholipid syndrome) warfarin remains preferred.

Bleeding is the foremost concern for patients on anticoagulants. A management plan should be established before any invasive procedure, dental extraction, or surgery; suspected intracranial, gastrointestinal, or urologic bleeding requires immediate evaluation.

Symptoms

Possible signs of over-anticoagulation (bleeding):
Blood in stool or black stools
Blood in urine
Uncontrolled nasal or gum bleeding
Unusual or large bruises
Headache, vision changes, or altered consciousness (intracranial bleeding — emergency)
Bloody vomit

Risk Factors

Advanced age (≥75 years)
Renal or hepatic dysfunction
Concomitant antiplatelet or NSAID use
Prior bleeding history
Uncontrolled hypertension
High fall risk
Vitamin K deficiency (in warfarin users)

When to See a Doctor?

If you experience any of the following symptoms, seek medical attention promptly:

  • Any sign of significant bleeding (emergency)
  • When INR is consistently outside the target range
  • When a new medication is added or removed (interaction check)
  • When a surgical or interventional procedure is planned
  • For anticoagulant management during pregnancy or breastfeeding

Treatment Methods

01
Warfarin: target INR 2-3 (2.5-3.5 for mechanical valves); regular INR monitoring
02
DOACs: fixed dosing, dose adjustment based on renal function
03
LMWH: especially for cancer-associated VTE and pregnant patients
04
Bleeding antidotes: vitamin K + PCC for warfarin; idarucizumab for dabigatran; andexanet alfa for factor Xa inhibitors
05
Perioperative bridging: indicated for warfarin; usually not required for DOACs
06
Patient education: medication adherence, foods and drugs to avoid, bleeding warning signs

Which Department to Visit?

You can visit our Hematoloji department for these complaints. Our specialist physicians will create the most suitable treatment plan for you.

Learn About Hematoloji Department

Let us help you

You can make an appointment with our specialists or contact us for your concerns.

Book AppointmentContact Us

Related Health Topics

Other articles from the same department you may want to explore.

Anaemia

Dahiliye (İç Hastalıkları)

Anaemia is a low haemoglobin level that reduces oxygen delivery, causing fatigue, pallor, and shortness of breath. It is not a disease itself but a sign of many underlying conditions. Most cases are correctable with appropriate diagnosis and treatment.

Iron Deficiency Anaemia

Dahiliye (İç Hastalıkları)

Iron deficiency anaemia develops when dietary intake, absorption, or losses create an iron shortfall, most often affecting women and children. Identifying the underlying cause is the core of management, alongside iron replacement.

Vitamin B12 Deficiency

Dahiliye (İç Hastalıkları)

Vitamin B12 deficiency can cause megaloblastic anaemia, neurological symptoms, and cognitive impairment. Early treatment with intramuscular or oral B12 largely prevents irreversible complications.

Hypertension (High Blood Pressure) Management

Dahiliye (İç Hastalıkları)

Hypertension is often called the silent killer because it progresses symptom-free for years and can damage the heart, brain, kidneys, and eyes. Regular monitoring, lifestyle change, and evidence-based drug therapy dramatically reduce cardiovascular risk.

Chronic Kidney Disease

Dahiliye (İç Hastalıkları)

Chronic kidney disease is one of the most common complications of chronic conditions such as diabetes and hypertension, and can be silent in its early stages.

Hepatitis B (HBV)

Dahiliye (İç Hastalıkları)

Hepatitis B is a DNA virus infection causing acute and chronic hepatitis with risk of cirrhosis and hepatocellular carcinoma; diagnosis integrates HBsAg, HBeAg, anti-HBc, and HBV DNA with management based on disease phase using nucleos(t)ide analogues (entecavir, tenofovir) and universal infant vaccination.

Hepatitis C (HCV)

Dahiliye (İç Hastalıkları)

Hepatitis C is an RNA virus causing chronic hepatitis that may progress to cirrhosis and hepatocellular carcinoma; modern direct-acting antiviral (DAA) pangenotypic regimens (sofosbuvir/velpatasvir, glecaprevir/pibrentasvir) achieve sustained virologic response over 95% in 8–12 weeks with universal adult screening and cure for nearly all patients.

Fatty Liver Disease

Dahiliye (İç Hastalıkları)

Non-alcoholic fatty liver disease (NAFLD) is closely related to obesity and metabolic syndrome and is largely reversible with early treatment.

Health Disclaimer: The information on this page is prepared for general informational purposes only. It does not replace medical diagnosis and treatment. Please consult your physician for your complaints. Saygı Hospital does not accept responsibility for actions taken based on the information on this page.